Xponance’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Buy |
16,710
+149
| +0.9% | +$4.92K | ﹤0.01% | 913 |
|
|
2025
Q1 | $666K | Buy |
16,561
+33
| +0.2% | +$1.33K | 0.01% | 844 |
|
|
2024
Q4 | $777K | Buy |
16,528
+853
| +5% | +$40.1K | 0.01% | 814 |
|
|
2024
Q3 | $828K | Buy |
15,675
+473
| +3% | +$25K | 0.01% | 767 |
|
|
2024
Q2 | $824K | Buy |
15,202
+1,348
| +10% | +$73K | 0.01% | 735 |
|
|
2024
Q1 | $971K | Buy |
13,854
+8,231
| +146% | +$577K | 0.01% | 730 |
|
|
2023
Q4 | $469K | Buy |
+5,623
| New | +$469K | 0.01% | 952 |
|
|
2023
Q1 | – | Sell |
-4,699
| Closed | -$215K | – | 1244 |
|
|
2022
Q4 | $215K | Buy |
4,699
+73
| +2% | +$3.35K | ﹤0.01% | 1110 |
|
|
2022
Q3 | $224K | Buy |
+4,626
| New | +$224K | ﹤0.01% | 1064 |
|